Literature DB >> 30453347

Increased Neutrophil Activation and Plasma DNA Levels in Patients with Pre-Eclampsia.

Yae Hu1,2, Hui Li3, Ruhong Yan1, Can Wang1, Yun Wang4, Ce Zhang1, Meng Liu1, Tiantian Zhou1, Weipei Zhu5, Hong Zhang5, Ningzheng Dong1,6,7, Qingyu Wu1,7,8.   

Abstract

Pre-eclampsia (PE) is a chronic inflammatory disease in pregnancy, which is associated with enhanced blood coagulation and high thrombotic risk. To date, the mechanisms underlying such an association are not fully understood. Previous studies reported high levels of plasma deoxyribonucleic acid (DNA) in PE women, but the cellular source of the circulation DNA remains unknown. In this study, we tested the hypothesis that activated neutrophils undergoing cell death, also called NETosis, may be responsible for the elevated plasma DNA levels in PE women. We analysed plasma samples from non-pregnant, normal pregnant and PE women and found high levels of double-stranded DNA, myeloperoxidase (an abundant neutrophil granular enzyme) and histones (the major nucleosome proteins) in PE-derived samples, indicating increased NETosis in the maternal circulation. The high plasma DNA levels positively correlated with enhanced blood coagulation in PE women. When isolated neutrophils from normal individuals were incubated with PE-derived plasma, an elevated NETosis-stimulating activity was detected. Further experiments showed that endothelial micro-particles, but not soluble proteins, in the plasma were primarily responsible for the NETosis-stimulating activity in PE women. These results indicate that circulating micro-particles from damaged maternal endothelium are a potent stimulator for neutrophil activation and NETosis in PE women. Given the pro-coagulant and pro-thrombotic nature of granular and nuclear contents from neutrophils, enhanced systemic NETosis may represent an important mechanism underlying the hyper-coagulability and increased thrombotic risk in PE. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30453347      PMCID: PMC6567982          DOI: 10.1055/s-0038-1675788

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  53 in total

1.  Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.

Authors:  X Y Zhong; H Laivuori; J C Livingston; O Ylikorkala; B M Sibai; W Holzgreve; S Hahn
Journal:  Am J Obstet Gynecol       Date:  2001-02       Impact factor: 8.661

Review 2.  The molecular basis of innate immunity in the horseshoe crab.

Authors:  Sadaaki Iwanaga
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

3.  Neutrophil activation induced by placental factors in normal and pre-eclamptic pregnancies in vitro.

Authors:  Y Wang; Y Gu; L Philibert; M J Lucas
Journal:  Placenta       Date:  2001-07       Impact factor: 3.481

4.  Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum.

Authors:  Dorine W Swinkels; Jacques B de Kok; Jan C M Hendriks; Erwin Wiegerinck; Petra L M Zusterzeel; Eric A P Steegers
Journal:  Clin Chem       Date:  2002       Impact factor: 8.327

Review 5.  Fetal cell-free nucleic acids in the maternal circulation: new clinical applications.

Authors:  Tuangsit Wataganara; Diana W Bianchi
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

Review 6.  Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface.

Authors:  Kristy Red-Horse; Yan Zhou; Olga Genbacev; Akraporn Prakobphol; Russell Foulk; Michael McMaster; Susan J Fisher
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

7.  Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia.

Authors:  M T Gervasi; T Chaiworapongsa; P Pacora; N Naccasha; B H Yoon; E Maymon; R Romero
Journal:  Am J Obstet Gynecol       Date:  2001-10       Impact factor: 8.661

8.  Activation of leukocytes during the uteroplacental passage in preeclampsia.

Authors:  Jan Roar Mellembakken; Pål Aukrust; Mette Kløvstad Olafsen; Thor Ueland; Kjetil Hestdal; Vibeke Videm
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

9.  Association of maternal endothelial dysfunction with preeclampsia.

Authors:  J C Chambers; L Fusi; I S Malik; D O Haskard; M De Swiet; J S Kooner
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

Review 10.  The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

Authors:  James N George
Journal:  Curr Opin Hematol       Date:  2003-09       Impact factor: 3.284

View more
  3 in total

1.  Neutrophil extracellular traps promote gastric cancer metastasis by inducing epithelial‑mesenchymal transition.

Authors:  Tong Zhu; Xiaoming Zou; Chunfa Yang; Liangliang Li; Bing Wang; Rong Li; Hongxuan Li; Zhangxuan Xu; Di Huang; Qingyun Wu
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

Review 2.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

Review 3.  Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.

Authors:  Xiyuan Bai; Joseph Hippensteel; Alida Leavitt; James P Maloney; David Beckham; Cindy Garcia; Qing Li; Brian M Freed; Diane Ordway; Robert A Sandhaus; Edward D Chan
Journal:  Med Hypotheses       Date:  2020-11-12       Impact factor: 1.538

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.